Gregg Owen Lehman - Net Worth and Insider Trading

Gregg Owen Lehman Net Worth

The estimated net worth of Gregg Owen Lehman is at least $537,522 dollars as of 2024-04-27. Gregg Owen Lehman is the President & CEO of MGC Diagnostics Corp and owns about 48,478 shares of MGC Diagnostics Corp (MGCD) stock worth over $534,712. Gregg Owen Lehman is also the Director of InfuSystems Holdings Inc and owns about 346 shares of InfuSystems Holdings Inc (INFU) stock worth over $2,810. Details can be seen in Gregg Owen Lehman's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Gregg Owen Lehman has not made any transactions after 2023-06-16 and currently still holds the listed stock(s).

Transaction Summary of Gregg Owen Lehman

To

Gregg Owen Lehman Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Gregg Owen Lehman owns 2 companies in total, including InfuSystems Holdings Inc (INFU) , and MGC Diagnostics Corp (MGCD) .

Click here to see the complete history of Gregg Owen Lehman’s form 4 insider trades.

Insider Ownership Summary of Gregg Owen Lehman

Ticker Comapny Transaction Date Type of Owner
INFU InfuSystems Holdings Inc 2023-06-16 director
MGCD MGC Diagnostics Corp 2014-05-29 President & CEO

Gregg Owen Lehman Latest Holdings Summary

Gregg Owen Lehman currently owns a total of 2 stocks. Among these stocks, Gregg Owen Lehman owns 48,478 shares of MGC Diagnostics Corp (MGCD) as of June 13, 2012, with a value of $534,712 and a weighting of 99.48%. Gregg Owen Lehman also owns 346 shares of InfuSystems Holdings Inc (INFU) as of June 16, 2023, with a value of $2,810 and a weighting of 0.52%.

Latest Holdings of Gregg Owen Lehman

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
MGCD MGC Diagnostics Corp 2012-06-13 48,478 11.03 534,712
INFU InfuSystems Holdings Inc 2023-06-16 346 8.12 2,810

Holding Weightings of Gregg Owen Lehman


Gregg Owen Lehman Form 4 Trading Tracker

According to the SEC Form 4 filings, Gregg Owen Lehman has made a total of 0 transactions in MGC Diagnostics Corp (MGCD) over the past 5 years. The most-recent trade in MGC Diagnostics Corp is the acquisition of 3,400 shares on June 13, 2012, which cost Gregg Owen Lehman around $19,482.

According to the SEC Form 4 filings, Gregg Owen Lehman has made a total of 12 transactions in InfuSystems Holdings Inc (INFU) over the past 5 years, including 0 buys and 12 sells. The most-recent trade in InfuSystems Holdings Inc is the sale of 25,000 shares on June 16, 2023, which brought Gregg Owen Lehman around $227,750.

Insider Trading History of Gregg Owen Lehman

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Gregg Owen Lehman Trading Performance

GuruFocus tracks the stock performance after each of Gregg Owen Lehman's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Gregg Owen Lehman is -6.52%. GuruFocus also compares Gregg Owen Lehman's trading performance to market benchmark return within the same time period. The performance of stocks bought by Gregg Owen Lehman within 3 months outperforms 2 times out of 6 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Gregg Owen Lehman's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Gregg Owen Lehman

Average Return

14.8%

Average return per transaction

Outperforming Transactions

67%

4 out of 6 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) -1.44 -6.52 2.85 14.8 19.98 18.49
Relative Return to S&P 500(%) -4.12 -7.08 0.85 4.19 7.2 3.7

Gregg Owen Lehman Ownership Network

Ownership Network List of Gregg Owen Lehman

No Data

Ownership Network Relation of Gregg Owen Lehman


Gregg Owen Lehman Owned Company Details

What does InfuSystems Holdings Inc do?

Who are the key executives at InfuSystems Holdings Inc?

Gregg Owen Lehman is the director of InfuSystems Holdings Inc. Other key executives at InfuSystems Holdings Inc include EVP-Chief HR Officer Jerod Funke , Executive Vice President Richard Dilorio , and Executive VP and CFO Barry G Steele .

InfuSystems Holdings Inc (INFU) Insider Trades Summary

Over the past 18 months, Gregg Owen Lehman made 3 insider transaction in InfuSystems Holdings Inc (INFU) with a net sale of 69,743. Other recent insider transactions involving InfuSystems Holdings Inc (INFU) include a net sale of 177,574 shares made by R. Rimmy Malhotra , a net sale of 80,838 shares made by Christopher R. Sansone , and a net purchase of 3,000 shares made by Barry G Steele .

In summary, during the past 3 months, insiders sold 0 shares of InfuSystems Holdings Inc (INFU) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 328,155 shares of InfuSystems Holdings Inc (INFU) were sold and 9,000 shares were bought by its insiders, resulting in a net sale of 319,155 shares.

InfuSystems Holdings Inc (INFU)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

InfuSystems Holdings Inc Insider Transactions

No Available Data

Gregg Owen Lehman Mailing Address

Above is the net worth, insider trading, and ownership report for Gregg Owen Lehman. You might contact Gregg Owen Lehman via mailing address: 309 Haddon Court, Franklin X1 37067.

Discussions on Gregg Owen Lehman

No discussions yet.